The activist director's complete exit and transfer of control to a new group of offshore investors, combined with the Nasdaq bid price deficiency, creates significant uncertainty. Monitor for the new board appointment, any potential reverse stock split to regain Nasdaq compliance, and the new investors' intentions regarding the company's direction. The 90-day indemnity holdback period ending ~December 24, 2026, is a near-term milestone.
Price Chart
Executive Summary
David E. Lazar, the activist director of Aterian, filed an exit amendment to his Schedule 13D, reporting that he sold substantially all of his convertible preferred shares to a group of 19 non-U.S. purchasers for $12 million, and converted his remaining 168,900 Series AA shares into 1,300,530 common shares. As a result, Lazar's beneficial ownership dropped from a controlling position to 3.1% of common stock, and he ceased to be a >5% holder on September 25, 2026. This represents a complete de-escalation and exit by the activist, transferring effective control to a new group of offshore investors who now hold ~92.5% of the fully diluted common stock.
Key Financial Metrics
Key Facts
- Lazar sold 706,100 Series AA and 1,750,000 Series AAA preferred shares to 19 non-U.S. purchasers for $12 million total.
- The sold preferred shares are convertible into 241,861,970 common shares, representing ~92.5% of the fully diluted outstanding common stock.
- Lazar converted his remaining 168,900 Series AA shares into 1,300,530 common shares on September 24, 2026.
- Lazar's beneficial ownership dropped to 8,038,030 common shares (3.1% of 261,129,410 shares outstanding).
- The filing states this is an 'exit filing' as Lazar ceased to beneficially own more than 5% on September 25, 2026.
- The purchasers obtained the right to appoint one board member and have one other director resign as a condition of the sale.
- Aterian received a Nasdaq bid price deficiency notice on September 2, 2026, with a 180-day cure period ending March 1, 2027.
Financial Impact
Lazar received $12 million for the preferred shares. The purchasers now control ~92.5% of the fully diluted common stock, representing a de facto change of control at a micro-cap company with a market cap of ~$13.4 million as of June 30, 2025.
Risk Factors
- Potential delisting from Nasdaq if the bid price remains below $1.00 beyond March 1, 2027.
- Massive dilution risk: the new investors' convertible preferred shares represent ~92.5% of the fully diluted common stock, which could flood the market if converted and sold.
- Uncertainty around the new controlling shareholders' intentions and strategy for the company.
- The company's micro-cap status and recent asset sale suggest limited ongoing business operations, increasing vulnerability.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D/A Filing (Primary) | 0001829126-26-010591 |
| Document: 0001829126-26-010591-index-headers.html | 0001829126-26-010591 |
| Document: 0001829126-26-010591-index.html | 0001829126-26-010591 |
| Document: 0001829126-26-010591.txt | 0001829126-26-010591 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $0.6300 | awaiting T+5 | — | $0.6230 (−1.11%) |
Oct 5, 2026 21d ago | 8-K | $0.6425 $0.5705 | ▲ +11.21% | ▲ +11.07% | $0.6230 (+3.04%) |
Oct 2, 2026 24d ago | SC 13D | $0.6356 $0.6076 | ▲ +4.41% | ▲ +4.83% | $0.6230 (+1.98%) |
Oct 2, 2026 24d ago | SC 13D | $0.6356 $0.6076 | ▲ +4.41% | ▲ +4.83% | $0.6230 (+1.98%) |
Sep 29, 2026 26d ago | SC 13D/A | $0.5866 $0.6109 | ▼ −4.14% | ▼ −2.23% | $0.6230 (−6.21%) |
Jul 29, 2026 12w ago | 3 | $0.3900 $0.4610 | ▲ +18.21% | ▲ +14.58% | $0.6230 (+59.74%) |
Jul 20, 2026 14w ago | S-3 | $1.03 $0.3605 | ▲ +65.00% | ▲ +63.77% | $0.6230 (+39.51%) |
Jul 13, 2026 15w ago | DEFA14A | $1.19 $1.30 | ▲ +9.24% | ▲ +10.03% | $0.6230 (−47.65%) |
Jul 8, 2026 15w ago | Press Release | $1.19 $1.28 | ▲ +7.56% | ▲ +7.69% | $0.6230 (−47.65%) |
Jul 6, 2026 16w ago | DEFA14A | $1.31 $1.15 | ▼ −12.21% | ▼ −12.70% | $0.6230 (−52.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers